Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research focused on Breast cancer and Oncology, with related work in Clinical Oncology, Cancer, DNA sequencing. Notable publications include 'JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer', 'CACA Guidelines for Holistic Integrative Management of Breast Cancer', and 'Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)'.
A radiogenomic multimodal and whole-transcriptome sequencing for preoperative prediction of axillary lymph node metastasis and drug therapeutic response in breast cancer: a retrospective, machine learning and international multicohort study
Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer
Clinical efficacy of fulvestrant versus exemestane as first-line therapies for Chinese postmenopausal oestrogen-receptor positive /human epidermal growth factor receptor 2 -advanced breast cancer (FRIEND study)
Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition)
CACA Guidelines for Holistic Integrative Management of Breast Cancer
Using an Improved Residual Network to Identify PIK3CA Mutation Status in Breast Cancer on Ultrasound Image
235P Efficacy and safety of first-line therapy with fulvestrant or exemestane for postmenopausal ER+/HER2- advanced breast cancer patients after adjuvant nonsteroidal aromatase inhibitor treatment: A randomized, open-label, multicenter study
Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018)
Guidelines of Chinese Society of Clinical Oncology (CSCO) on Diagnosis and Treatment of Breast Cancer (2020 version)
JAK1 as a prognostic marker and its correlation with immune infiltrates in breast cancer
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
Multicenter cross‑sectional screening of the BRCA gene for Chinese high hereditary risk breast cancer populations